Are you Dr. Powell?
Join over one million U.S. Physicians, Nurse Practitioners and PAs, already on Doximity.
- Gain access to free telehealth tools, such as our "call shielding" and one-way patient texting.
- Connect with colleagues in the same hospital or clinic.
You already have 77 invites waiting! - Read the latest clinical news, personalized to your specialty.
Office
600 N Wolfe St
Baltimore, MD 21287Phone+1 410-955-8964
Summary
- Dr. Jonathan Powell, MD is an oncologist in Baltimore, Maryland. He is currently licensed to practice medicine in Maryland and Massachusetts. He is an Associate Professor at Johns Hopkins University School of Medicine.
Education & Training
- Brigham and Women's Hospital/Massachusetts General Hospital/Dana-Farber Cancer InstituteFellowship, Hematology and Medical Oncology, 1995 - 1998
- Johns Hopkins UniversityResidency, Internal Medicine, 1992 - 1995
- Emory University School of MedicineClass of 1992
Certifications & Licensure
- MD State Medical License 1996 - 2025
- MA State Medical License 1995 - 2000
Awards, Honors, & Recognition
- Elected Member The American Society for Clinical Investigation, 2010
Publications & Presentations
PubMed
- 392 citationsDeveloping a pro-regenerative biomaterial scaffold microenvironment requires T helper 2 cells.Kaitlyn Sadtler, Kenneth Estrellas, Brian W. Allen, Matthew T. Wolf, Hongni Fan
Science. 2016-04-15 - 302 citationsIntegrating canonical and metabolic signalling programmes in the regulation of T cell responses.Kristen N. Pollizzi, Jonathan D. Powell
Nature Reviews. Immunology. 2014-07-01 - 157 citationsAcid Suspends the Circadian Clock in Hypoxia through Inhibition of mTORZandra E. Walton, Chirag H. Patel, Rebekah C. Brooks, Yongjun Yu, Arig Ibrahim-Hashim
Cell. 2018-06-28
Press Mentions
- GSK-Backed Biotech Gets $50M Upfront in Autoimmune Disease Deal with LillyMarch 31st, 2020
- Another Immunometabolism Deal? Johns Hopkins Spinout Dracen Lands $36M Investment from DeerfieldMarch 22nd, 2018
- Corvus Pharmaceuticals to Host R&D Day Highlighting the Role of the Adenosine Pathway in Immuno-OncologyMarch 9th, 2017
- Join now to see all